MoneyWorks4Me

Rubicon Research - Quaterly Results

04 Feb 2026 Evaluate
A fair growth of 23.21% in the revenue at Rs. 3017.11 millions was reported in the December 2025 quarter as compared to Rs. 2448.73 millions during year-ago period.The Net proft of the company remain more or less same to Rs. 371.81  millions from Rs. 382.28 millions ,decline by -2.74%.Operating Profit saw a handsome growth to 665.48 millions from 662.35 millions in the quarter ended December 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202512 202412 % Var
Sales 3017.11 2448.73 23.21 3017.11 2448.73 23.21 3017.11 2448.73 23.21
Other Income 43.01 23.30 84.59 43.01 23.30 84.59 43.01 23.30 84.59
PBIDT 665.48 662.35 0.47 665.48 662.35 0.47 665.48 662.35 0.47
Interest 75.09 72.50 3.57 75.09 72.50 3.57 75.09 72.50 3.57
PBDT 590.39 589.85 0.09 590.39 589.85 0.09 590.39 589.85 0.09
Depreciation 95.11 79.32 19.91 95.11 79.32 19.91 95.11 79.32 19.91
PBT 495.28 510.53 -2.99 495.28 510.53 -2.99 495.28 510.53 -2.99
TAX 123.47 128.25 -3.73 123.47 128.25 -3.73 123.47 128.25 -3.73
Deferred Tax 22.32 -39.52 -156.48 22.32 -39.52 -156.48 22.32 -39.52 -156.48
PAT 371.81 382.28 -2.74 371.81 382.28 -2.74 371.81 382.28 -2.74
Equity 164.75 152.10 8.32 164.75 152.10 8.32 164.75 152.10 8.32
PBIDTM(%) 22.06 27.05 -18.45 22.06 27.05 -18.45 22.06 27.05 -18.45
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..